IFAPP Academy Director and Module Chair, Xavier Luria

Xavier Luria, MD

Independent consultant on Drug Development and Drug Regulation, located in Barcelona and London


He was Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA) during 2005-2012, and previously held leadership positions in the biopharmaceutical industry for more than eighteen years, covering international clinical development, pharmacovigilance, biostatistics, and medical affairs.

In addition to Dr. Luria’s specialty in internal medicine, pharmaceutical medicine and biostatistics (University Autonomous Barcelona), he has developed expertise in several specific therapeutic areas, carried out postgraduate qualification in clinical pharmacology, drug development and regulation (Tufts University School of Medicine, Boston), he is a recognized expert on regulatory systems and benefit-risk assessment (modeling, development, and methodologies) and has been lecturer at the UCSF.

Furthermore, he is a consultant for governments in Europe and Latin America and professor of Regulation of Life Science Industry at the IE Business School and lecturer at several other academic institutions in Europe and the USA.

He is currently member of the Kinesys Advisory Board (http://www.kinesysconsulting.com), scientific and regulatory advisor at TFS (http://www.tfscro.com), Premier Expert Consultant at NDA Partners (http://www.ndapartners.com), Senior Advisor and UK representative of SFL (http://www.sfl-services.com/en/home), and he is also a member of the European Advisory Board of RAPS (http://www.raps.org).